蛍光透視装置の世界市場-2022-2029

市場の概要

蛍光透視装置の市場規模は、予測期間（2022～2029年）にCAGR5.22%で成長すると予測されています。

蛍光透視装置とは、X線映画と同じようにX線画像をモニターに表示する医療用画像診断装置です。X線を用いて、X線レントゲン撮影やコンピュータ断層撮影のように、対象物の内部をリアルタイムで動画化することを実現するものです。心臓や腸の病気などの診断（原因究明）に使用されることがあります。また、インプラントや注射などの治療や整形外科手術のガイドとしても使用されます。臓器、関節、筋肉、骨の内部を観察することができます。

市場力学

インターベンショナル・ラジオロジー（interventional radiology）の施術数の増加、低侵襲手術の増加、技術的進歩の増大、心血管疾患の有病率の上昇は、世界の蛍光透視装置市場の主要な市場促進要因の一部となっています。

透視画像診断装置における最新の技術革新が、市場の成長を促進すると予想されます。

透視誘導処置中の不要な放射線被曝の劇的な低減に注力する非公開の医療技術企業であるControlRad, Inc.は、2019年5月にFDA承認のControlRad Traceを発売しました。ControlRad Traceは、既存のモバイルCアームに組み込むことで、あらゆる透視画像処置における放射線を低減することができる唯一の技術です。さらに、シーメンス・ヘルスマイヤーズ傘下のCorindus社は、掲載論文「Circulation：Cardiovascular Interventions」2020年5月号に、CorPath GRX Systemを用いたロボットPCIは、透視時間と造影剤の利用率を高めながら、手動PCIと比較して患者の放射線被ばくを20％低減することが記載されています。このように、上記の要因から、予測期間において市場の牽引役となることが予想されます。

機器の高コストが市場成長の妨げになることが予想されます。

しかし、モバイルシステムはその高度な機能や特徴から、コストも高く、20万米ドル以上となっています。先進的なモバイルユニットには20KWの発電機が取り付けられており、高密度な組織への浸透を可能にしています。GEヘルスケア社製の高価なものでは、OEM 9900 Eliteやジーム・イメージング社のvision RFDなどがあり、大型画像ディスプレイを搭載し、正確な画像評価を可能にしています。高額な機器代以外にも、プリンターやDICOMボックスなどの直接費用が発生し、総所有コストが増加します。このため、機器の使用期間が平均寿命より長くなってしまいます。このように、上記の要因から、予測期間において市場は阻害されることが予想されます。

COVID-19の影響分析

COVID-19の大流行がCアーム市場に影響を及ぼすと予想されます。COVID-19のために延期された、一般的に選択的である画像誘導処置は、Cアームを使用します。人工呼吸器などCOVID-19の治療をサポートする機器に注力するようになったため、今回のパンデミックでは、病院は高額な設備投資を控えた可能性があります。例えば、British Journal of Surgery誌に掲載された研究によると、2020年には世界中で約2,840万件の待機手術がキャンセルまたは延期されると予想されています。この予測は、COVID-19による12週間のピーク時の病院サービスの混乱に基づいています。COVID-19の大流行により、インドでは58万件以上の予定されていた手術の中止や延期が余儀なくされました。しかし、COVID-19陽性で手術が必要な患者に対応するため、欧州泌尿器科学会では特別な設備を備えた手術室を作ることを推奨しています。この部屋には、放射線技師やヘルスケア専門家のための移動式Cアーム透視X線システムが必要となります。したがって、COVID-19の症例数の増加や地域全体のヘルスケアシステムへの大きな影響を考慮すると、予測期間中、市場は現在の安定した成長率の軌跡を維持すると予想されます。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 透視イメージングにおける最新の技術革新が市場成長を促進すると予想されます。
  • 抑制要因
    • 機器の高コストが市場成長の妨げになると予想されます。
  • 機会
  • 影響分析

第5章 産業分析

• ポーターの5つの力
• サプライチェーン
• プライシング分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• まとめ

第7章 製品タイプ別

• 蛍光透視装置
• 固定式Cアーム
• モバイルフルサイズアーム
• 移動式ミニCアーム

第8章 アプリケーション別

• 診断アプリケーション
  • 心臓病学
  • 泌尿器科・腎臓内科
  • 神経血管
  • その他
• 外科分野
  • 整形外科・外傷外科
  • 脳神経外科
  • 心臓血管外科
  • 消化器外科
  • その他

第9章 エンドユーザー別

• 病院
• 診断センター
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A（合併・買収）分析

第12章 企業プロファイル

• Siemens Healthcare
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• GE Healthcare
• Philips Healthcare
• Carestream Health, Inc.
• Canon Medical Systems
• Hitachi Medical Systems
• Shimadzu Corporation
• Ziehm Imaging GmbH
• Fujifilm Medical Systems
• Lepu Medical Technology

第13章 蛍光透視装置の世界市場-DataM

Market Overview

Fluoroscopy Equipment Market size was valued around US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 5.22% during the forecast period (2022-2029).

Fluoroscopy equipment is medical imaging equipment that displays the X-ray image on a monitor, the same as an X-ray movie. It uses X-rays to achieve real-time moving images of the inside of an object, like X-ray radiography and computed tomography. Fluoroscopy can be used to diagnose (determine the cause of) a health problem such as heart or intestinal disease. It is also used to guide treatments such as implants or injections and in orthopedic surgery. It allows the doctor to look inside organs, joints, muscles, and bones.

Market Dynamics

Increasing number of interventional radiology procedures, the rising number of minimally invasive procedures, increased technological advancements, and the growing prevalence of cardiovascular diseases are some of the key market drivers of Global Fluoroscopy Equipment Market.

Latest innovations in fluoroscopic imaging equipment is expected to drive market growth.

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, launched the FDA-approved ControlRad Trace in May 2019. ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure. Moreover, Corindus, a Siemens Healthineers company, announced in the published article "Circulation: Cardiovascular Interventions" in May 2020 states that robotic PCI with the CorPath GRX System reduces patient radiation exposure by 20% compared to manual PCI while increasing fluoroscopy time and contrast utilization. Thus, from the above-mentioned factors, the market is expected to drive in the forecast period.

The high cost of equipment is expected to hamper the market growth.

However, due to their advanced features and functionalities, mobile systems also have a high cost, which is more than USD 200,000. Advanced mobile units have 20KW generators attached, allowing them to penetrate dense tissues. The costliest ones manufactured by GE Healthcare include OEM 9900 Elite and Ziehm Imaging's vision RFD, which include large image displays to enable accurate image evaluation. Apart from the high equipment cost, there are other direct expenses for printers and DICOM boxes which increase the total cost of ownership. Due to this, the usage of the equipment is extended beyond its average life. Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to have an effect on the market for C-arms. Image-guided procedures, which are typically elective and were delayed because of COVID-19, use C-arms. Due to their increased focus on ventilators and other COVID-19 treatment-supporting equipment, hospitals may have refrained from investing in expensive capital equipment during the current pandemic. For instance, according to the study published in the British Journal of Surgery, approximately 28.4 million elective surgeries worldwide were anticipated to be canceled or postponed in 2020. This prediction was based on 12 weeks of peak hospital service disruption caused by COVID-19. The COVID-19 pandemic has forced the cancellation or postponement of more than 580,000 scheduled surgeries in India. However, to handle COVID-19-positive patients require surgery, it is recommended by the European Association of Urology that a specially furnished operating room should be created. This room will require a mobile C-arm fluoroscopic X-ray system for radiology and healthcare professionals. Therefore, it is anticipated that the market will maintain its current steady growth rate trajectory during the forecast period, considering the rising cases of COVID-19 and its significant impact on healthcare systems throughout the region.

Segment Analysis

Fluoroscopy devices segment is expected to hold the largest market share in fluoroscopy equipment

The fluoroscopy devices segment accounted for the largest market share in 2021. This is owing to the usage of a wide array of procedures such as image-guided biopsy, angiography, and discography. In addition to this, fluoroscopes are increasingly used in previously unexplored applications such as nondestructive testing of medical devices and quality assurance. The increasing number of recent FDA approvals is expected to accelerate market growth. For instance, on August 4, 2022, Xoran Technologies received FDA 510(k) clearance for TRON, a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system. As of February 21, 2019, Agfa Healthcare's DR 800 multipurpose digital radiography (DR) imaging system with tomosynthesis received FDA 510(k) clearance. The DR 800 provides a single solution for advanced clinical applications, multi-slice imaging, fluoroscopy, radiography, and radiography, supporting radiology in value-based care organizations with greater adaptability, functionality, and effectiveness. Thus, from the above-mentioned factors, the market segment is accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global fluoroscopy equipment

North America region accounted for the largest market share in 2021. The increasing prevalence of cardiovascular and orthopedic surgeries, high standards of healthcare infrastructure, the high frequency of diagnostic examination, the rising geriatric population, and the increasing prevalence of chronic diseases in the U.S. are the factors to drive the market in the forecast period. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups in the U.S. Cardiovascular disease claims one life in the U.S. every 34 seconds. 1 in 5 deaths in the U.S. in 2020 was caused by heart disease, which affected approximately 697,000 people. Additionally, in 2020, adults under 65 years old accounted for about 2 in 10 deaths from CAD.

Moreover, because of its developed healthcare system, the U.S. has the largest installed base of C-arms globally. Additionally, all C-arms are replaced following the replacement schedule due to the strict regulations in the U.S., according to the healthcare regulatory authorities, which guarantees that the new C-Arm sales in the country are consistent. Thus, from the above factors, the North America region is expected to hold the largest market share in the forecast period.

Global Fluoroscopy Equipment Market- Competitive Landscape

Major key players in the fluoroscopy equipment market include Siemens Healthcare, GE Healthcare, Philips Healthcare, Carestream Health, Inc., Canon Medical Systems, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Fujifilm Medical Systems and Lepu Medical Technology.

For instance, on January 13, 2021, the FDA approved Siemens Cios Flow mobile C-arm in the U.S. It is designed to be a general-purpose C-arm that can be easily used in various cases and is intended for orthopedics, vascular surgery, trauma, spinal surgery, and other fields.

Shimadzu Corporation:

Overview:

Shimadzu Corporation is a Japanese public KK company that manufactures measuring devices, medical equipment, and precision instruments. In order to use advances in science and technology to make society more convenient, secure, and safe, the company operates in four segments: analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Shimadzu Scientific Instruments (SSI) is the Shimadzu Corporation's American subsidiary (Kyoto, Japan). SSI was founded in 1975 as a distribution hub that offered labs and service providers in the Americas analytical solutions. Shimadzu U.S.A. Manufacturing provides HPLC, GC-MS/MS, LC-MS/MS, and other high-tech products to the U.S. market through its ten regional offices strategically positioned across the country. These offices are staffed with experienced technical specialists, service and sales engineers, and a state-of-the-art Customer Training and Education Center.

Product Portfolio:

OPESCOPE ACTENO: It is a mobile C-arm Imaging System whose main applications are X-ray fluoroscopy and radiography during surgery. Lock mechanisms allow individual movement locking, ensuring quick and accurate positioning.

The global fluoroscopy equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Latest innovations in fluoroscopic imaging are expected to drive market growth.
  • 4.1.2. Restraints:
    • 4.1.2.1. The high cost of equipment is expected to hamper the market growth.
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces
• 5.2. Supply Chain
• 5.3. Pricing Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Fluoroscopy Devices*
  • 7.2.1.1. Introduction
  • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Fixed C-Arms
• 7.4. Mobile Full Size C-Arms
• 7.5. Mobile Mini C-Arms

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Diagnostic Applications
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth
  • 8.2.3. Cardiology *
  • 8.2.4. Urology and Nephrology
  • 8.2.5. Neurovascular
  • 8.2.6. Others
• 8.3. Surgical Applications
  • 8.3.1. Orthopedic & Trauma Surgeries
  • 8.3.2. Neurosurgeries
  • 8.3.3. Cardiovascular Surgeries
  • 8.3.4. Gastrointestinal Surgeries
  • 8.3.5. Others

9. By End user

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 9.1.2. Market Attractiveness Index, By End user
• 9.2. Hospitals*
  • 9.2.1.1. Introduction
  • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Diagnostic Centers
• 9.4. Ambulatory Surgery Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Siemens Healthcare*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. GE Healthcare
• 12.3. Philips Healthcare
• 12.4. Carestream Health, Inc.
• 12.5. Canon Medical Systems
• 12.6. Hitachi Medical Systems
• 12.7. Shimadzu Corporation
• 12.8. Ziehm Imaging GmbH
• 12.9. Fujifilm Medical Systems
• 12.10. Lepu Medical Technology

LIST NOT EXHAUSTIVE

13. Global Fluoroscopy Equipment Market- DataM

• 13.1. Appendix
• 13.2. About Us and Applications
• 13.3. Contact Us